Title
Clinilabs Drug Development Corporation – The only CRO focused exclusively on central nervous system (CNS) drug development, an area of significant unmet need.
Go Home
Category
Description
Address
Phone Number
+1 609-831-2326 (US) | Message me
Site Icon
Clinilabs Drug Development Corporation – The only CRO focused exclusively on central nervous system (CNS) drug development, an area of significant unmet need.
Tags
Page Views
0
Share
Update Time
2022-08-22 00:46:23

"I love Clinilabs Drug Development Corporation – The only CRO focused exclusively on central nervous system (CNS) drug development, an area of significant unmet need."

www.clinilabs.com VS www.gqak.com

2022-08-22 00:46:23

AboutLeadershipScientific Advisory BoardGlobal OfficesStrategic AlliancesMedia CenterCase StudiesWhite PapersWebinarsVideos Close CloseServicesDecentralized TrialsPhase 2 – 3 ServicesProject ManagementMonitoringMedical WritingSite SelectionDecentralized Trials CloseData ServicesElectronic Case Report FormsBiostatisticsProgramming and Database Architecture ClosePhase I ServicesNew Jersey Phase 1 UnitNYC Clinical Research UnitsSpecialty StudiesSpecialty ProceduresCRU on DemandSubject DatabaseSubject Pre-Screening & Authentication CloseTechnologyCore LaboratoriesAdvisory & Regulatory CloseNews & EventsLatest NewsUpcoming EventsMeet With Us CloseVolunteersPatient TestimonialsFrequently Asked QuestionsRefer a Friend ProgramPatient TestimonialsCurrent StudiesWays to Contact Us CloseInvestigatorsCareersContact Close.switcher {font-family:Arial;font-size:12pt;text-align:left;cursor:pointer;overflow:hidden;width:173px;line-height:17px;}.switcher a {text-decoration:none;display:block;font-size:12pt;-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;}.switcher a img {vertical-align:middle;display:inline;border:0;padding:0;margin:0;opacity:0.8;}.switcher a:hover img {opacity:1;}.switcher .selected {background:#fff linear-gradient(180deg, #efefef 0%, #fff 70%);position:relative;z-index:9999;}.switcher .selected a {border:1px solid #ccc;color:#666;padding:3px 5px;width:161px;}.switcher .selected a:after {height:24px;display:inline-block;position:absolute;right:10px;width:15px;background-position:50%;background-size:11px;background-image:url("data:image/svg+xml;utf8,");background-repeat:no-repeat;content:""!important;transition:all .2s;}.switcher .selected a.open:after {-webkit-transform: rotate(-180deg);transform:rotate(-180deg);}.switcher .selected a:hover {background:#fff}.switcher .option {position:relative;z-index:9998;border-left:1px solid #ccc;border-right:1px solid #ccc;border-bottom:1px solid #ccc;background-color:#eee;display:none;width:171px;max-height:198px;-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;overflow-y:auto;overflow-x:hidden;}.switcher .option a {color:#000;padding:3px 5px;}.switcher .option a:hover {background:#fff;}.switcher .option a.selected {background:#fff;}#selected_lang_name {float: none;}.l_name {float: none !important;margin: 0;}.switcher .option::-webkit-scrollbar-track{-webkit-box-shadow:inset 0 0 3px rgba(0,0,0,0.3);border-radius:5px;background-color:#f5f5f5;}.switcher .option::-webkit-scrollbar {width:5px;}.switcher .option::-webkit-scrollbar-thumb {border-radius:5px;-webkit-box-shadow: inset 0 0 3px rgba(0,0,0,.3);background-color:#888;} English Chinese (Simplified) Chinese (Traditional) English French German Japanese Spanish#goog-gt-tt {display:none !important;}.goog-te-banner-frame {display:none !important;}.goog-te-menu-value:hover {text-decoration:none !important;}.goog-text-highlight {background-color:transparent !important;box-shadow:none !important;}body {top:0 !important;}#google_translate_element2 {display:none!important;}Home PageClinilabs Inc2021-08-24T14:38:04+00:00Clinilabs Drug Development Corporation is the CRO for CNS Clinilabs is a global, full-service CRO dedicated to providing a full range of CNS drug development services to pharmaceutical and biotechnology companies, from first-in-human to Phase 3 trials. Learn More The CRO for CNSThe only CRO focused exclusively on central nervous system (CNS) drug development, an area of significant unmet need.Substance Use DisordersMental HealthNeurological DisordersRare and Ultra-Rare CNS DiseasesBringing new therapies to patients living with mental health, neurological and substance use disorders.Experience, Scientific Knowledge and Operational Expertise Combine With Accountability, Responsibility and IntegrityLatest News & Updates.fusion-button.button-1 .fusion-button-text, .fusion-button.button-1 i {color:#ffffff;}.fusion-button.button-1 {border-width:0px;border-color:#ffffff;}.fusion-button.button-1 .fusion-button-icon-divider{border-color:#ffffff;}.fusion-button.button-1:hover .fusion-button-text, .fusion-button.button-1:hover i,.fusion-button.button-1:focus .fusion-button-text, .fusion-button.button-1:focus i,.fusion-button.button-1:active .fusion-button-text, .fusion-button.button-1:active{color:#ffffff;}.fusion-button.button-1:hover, .fusion-button.button-1:focus, .fusion-button.button-1:active{border-width:0px;border-color:#ffffff;}.fusion-button.button-1:hover .fusion-button-icon-divider, .fusion-button.button-1:hover .fusion-button-icon-divider, .fusion-button.button-1:active .fusion-button-icon-divider{border-color:#ffffff;}.fusion-button.button-1{width:auto;}more newsShannon Woodruff2022-08-19T18:58:40+00:00Cybin and Clinilabs Granted Schedule I DEA License for CYB003 Phase 1/2a First-In-Human Clinical TrialTORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, and its [...]Shannon Woodruff2022-08-19T18:57:05+00:00Clinilabs Drug Development Corporation Begins Enrollment for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive DisorderEATONTOWN, N.J.--(BUSINESS WIRE)--Clinilabs Drug Development Corporation (“Clinilabs”), a global, full-service contract research organization with deep expertise in central nervous system drug [...]Jeanine Estrada2022-04-28T14:16:12+00:00Cybin Partners with Clinilabs Drug Development Corporation for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive DisorderApril 21, 2022 12:00 UTC TORONTO--(BUSINESS WIRE)-- Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (Cybin or the Company), a biopharmaceutical company focused on progressing “Psychedelics to TherapeuticsTM”, [...]Connect With UsConnect with us online, or come visit us atan upcoming industry event!.fusion-button.button-2 .fusion-button-text, .fusion-button.button-2 i {color:#ffffff;}.fusion-button.button-2 {border-width:0px;border-color:#ffffff;}.fusion-button.button-2 .fusion-button-icon-divider{border-color:#ffffff;}.fusion-button.button-2:hover .fusion-button-text, .fusion-button.button-2:hover i,.fusion-button.button-2:focus .fusion-button-text, .fusion-button.button-2:focus i,.fusion-button.button-2:active .fusion-button-text, .fusion-button.button-2:active{color:#ffffff;}.fusion-button.button-2:hover, .fusion-button.button-2:focus, .fusion-button.button-2:active{border-width:0px;border-color:#ffffff;}.fusion-button.button-2:hover .fusion-button-icon-divider, .fusion-button.button-2:hover .fusion-button-icon-divider, .fusion-button.button-2:active .fusion-button-icon-divider{border-color:#ffffff;}.fusion-button.button-2{width:auto;}Connect Today!Free Webinar: Drug Development and the Changing Alzheimer’s Disease Therapeutic LandscapeSeptember 22 @ 1:00 pm - 2:00 pmCNS SummitNovember 17 - November 20 at Boca Raton Resort and Club, A Waldorf Astoria ResortClinical Trials on Alzheimer’s Disease (CTAD)November 29 - December 2 at Hilton Union SquareA PATIENT-CENTRIC APPROACH TO CLINICAL TRIALSVolunteers & PatientsWe empower study participants by educating them about clinical research, enabling them to make informed decisions regarding study participation..fusion-button.button-3 .fusion-button-text, .fusion-button.button-3 i {color:#ffffff;}.fusion-button.button-3 {border-width:0px;border-color:#ffffff;}.fusion-button.button-3 .fusion-button-icon-divider{border-color:#ffffff;}.fusion-button.button-3:hover .fusion-button-text, .fusion-button.button-3:hover i,.fusion-button.button-3:focus .fusion-button-text, .fusion-button.button-3:focus i,.fusion-button.button-3:active .fusion-button-text, .fusion-button.button-3:active{color:#ffffff;}.fusion-button.button-3:hover, .fusion-button.button-3:focus, .fusion-button.button-3:active{border-width:0px;border-color:#ffffff;}.fusion-button.button-3:hover .fusion-button-icon-divider, .fusion-button.button-3:hover .fusion-button-icon-divider, .fusion-button.button-3:active .fusion-button-icon-divider{border-color:#ffffff;}.fusion-button.button-3{width:auto;}I’m interested in a studyNEW POSSIBILITIES FORInvestigatorsClinilabs collaborates with investigator sites worldwide to conduct clinical trials that lead to new drug approvals. Become an investigator in our global network!.fusion-button.button-4 .fusion-button-text, .fusion-button.button-4 i {color:#ffffff;}.fusion-button.button-4 {border-width:0px;border-color:#ffffff;}.fusion-button.button-4 .fusion-button-icon-divider{border-color:#ffffff;}.fusion-button.button-4:hover .fusion-button-text, .fusion-button.button-4:hover i,.fusion-button.button-4:focus .fusion-button-text, .fusion-button.button-4:focus i,.fusion-button.button-4:active .fusion-button-text, .fusion-button.button-4:active{color:#ffffff;}.fusion-button.button-4:hover, .fusion-button.button-4:focus, .fusion-button.button-4:active{border-width:0px;border-color:#ffffff;}.fusion-button.button-4:hover .fusion-button-icon-divider, .fusion-button.button-4:hover .fusion-button-icon-divider, .fusion-button.button-4:active .fusion-button-icon-divider{border-color:#ffffff;}.fusion-button.button-4{width:auto;}Let’s collaborate Phone: (646) 215-6400Fax: (646) 215-6401Email: [email protected] .widget h4 {color:#ffffff;}.fusion-widget-area-1 .widget .heading h4 {color:#ffffff;}.fusion-widget-area-1 .widget h4 {font-size:17px;}.fusion-widget-area-1 .widget .heading h4 {font-size:17px;}.fusion-widget-area-2 .widget h4 {color:#ffffff;}.fusion-widget-area-2 .widget .heading h4 {color:#ffffff;}.fusion-widget-area-2 .widget h4 {font-size:17px;}.fusion-widget-area-2 .widget .heading h4 {font-size:17px;}VOLUNTEERSVolunteersFrequently Asked QuestionsCurrent StudiesOnline Screening.fusion-widget-area-3 .widget h4 {color:#ffffff;}.fusion-widget-area-3 .widget .heading h4 {color:#ffffff;}.fusion-widget-area-3 .widget h4 {font-size:17px;}.fusion-widget-area-3 .widget .heading h4 {font-size:17px;}INVESTIGATORSRegister now.fusion-widget-area-4 .widget h4 {color:#ffffff;}.fusion-widget-area-4 .widget .heading h4 {color:#ffffff;}.fusion-widget-area-4 .widget h4 {font-size:17px;}.fusion-widget-area-4 .widget .heading h4 {font-size:17px;}MEDIA CENTERCase StudiesWhite PapersWebinarsVideos.fusion-widget-area-5 .widget h4 {color:#ffffff;}.fusion-widget-area-5 .widget .heading h4 {color:#ffffff;}.fusion-widget-area-5 .widget h4 {font-size:17px;}.fusion-widget-area-5 .widget .heading h4 {font-size:17px;}CONTACT USGeneral InquiriesMeet With UsCareers Copyright © 2001-2022 Clinilabs Inc. All rights reserved. Privacy Policy.FacebookInstagramLinkedInYouTubeYelp